$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Régulation «en aval de l'ARNm de TNF par NO dans les cellules RAW 264.7
Nitric oxide downregulates tumour necrosis factor mRNA in RAW 264.7 cells

Research in immunology, v.149 no.2, 1998년, pp.139 - 150  

Sinha, B. (Corresponding author.) ,  Eigler, A. ,  Baumann, K.H. ,  Greten, T.F. ,  Moeller, J. ,  Endres, S.

Abstract AI-Helper 아이콘AI-Helper

SummaryNitric oxide (NO) and tumour necrosis factor (TNF) are essential mediators in a number of biological processes, including the immune response. TNF stimulates NO production via expression of inducible NO synthase (iNOS), with L-arginine being the only substrate. Previously, we demonstrated tha...

Abstract

Sachant que la synthèse de TNF (facteur nécrotique tumoral), induite par le LPS (lipopolyoside), est inhibée par NO, nous avons cherché à savoir si une réduction de l'activité de TNF est reflétée au niveau de l'ARNm de TNF dans la lignée RAW 264.7 de macrophages murins. L'ARNm a été quantifié par la méthode Northern avec une sonde marquée par α 32P-dCTP. Les cellules stimulées par 10 μg de LPS/ml en l'absence de L-arginine (afin de prévenir la formation de NO endogène) contiennent plus d'ARNm que les cellules additionnées de 1 mM de L-arginine en contiennent, 14 et 20 h après stimulation; aucune différence n'est observée après 4 h. Une telle cinétique est compatible avec l'implication de la NO synthase inductible. La demi-vie de l'ARNm en présence de NO est approximativement la moitié de celle notée en l'absence de L-arginine (41 min au lieu de 77 min). La L-citrulline, à 1 mM, qui est recyclée en L-arginine dans les cellules, compense entièrement la réduction de l'activité du TNF, et ces résultats suggèrent que le NO endogène régule l'ARNm du TNF surtout en réduisant la demi-vie. En outre, une bande supplémentaire d'environ 1,4 kb (hybridation avec TNF) est toujours observé chez les cellules non stimulées. Cela peut correspondre à un ARNm spécifiquement hydrolysé dans la région riche en AU, reflétant possiblement un autre point de régulation de l'expression du TNF.

주제어

참고문헌 (53)

  1. Lancet Änggård 343 1199 1994 10.1016/S0140-6736(94)92405-8 Nitric oxide: mediator, murderer, and medicine 

  2. Annu. Rev. Immunol. Beutler 7 625 1989 10.1146/annurev.iy.07.040189.003205 The biology of cachectin/TNF - a primary mediator of the host response 

  3. Science Beutler 232 977 1986 10.1126/science.3754653 Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance 

  4. Biochem. Biophys. Res. Commun. Beutler 152 973 1988 10.1016/S0006-291X(88)80379-6 Assay of a ribonuclease that preferentially hydrolyses mRNAs containing cytokinederived UA-rich instability sequences 

  5. Beutler 86 192 1989 Evolution of the genome and the genetic code: selection at the dinucleotide level by methylation an polyribonucleotide cleavage 

  6. J. Immunol. Bouma 153 4159 1994 10.4049/jimmunol.153.9.4159 Differential regulatory effects of adenosine on cytokine release by activated human monocytes 

  7. Caput 83 1670 1986 Identification of a common nucleotide sequence in the 3′-untranslated region of mRNA molecules specifying inflammatory mediators 

  8. Anal. Biochem. Chomczynski 162 156 1987 10.1016/0003-2697(87)90021-2 Single-step method of RNA isolation by acid guanidinium thiocyanatephenol-chloroform extraction 

  9. Mol. Cell. Biol. Collart 10 1498 1990 10.1128/MCB.10.4.1498 Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B 

  10. J. Clin. Invest. De Caterina 96 60 1995 10.1172/JCI118074 Nitric oxide decreases cytokine-induced endothelial activation 

  11. Scand. J. Immunol. Eigler 45 132 1997 10.1046/j.1365-3083.1997.d01-377.x Endogenous adenosine curtails lipopolysaccharide-stimulated tumour necrosis factor synthesis 

  12. J. Immunol. Eigler 154 4048 1995 10.4049/jimmunol.154.8.4048 Exogenous and endogenous nitric oxide attenuates tumor necrosis factor synthesis in the murine macrophage cell line RAW 264.7 

  13. Biochem. Biophys. Res. Commun. Eigler 196 494 1993 10.1006/bbrc.1993.2277 Nitric oxide-releasing agents enhance cytokine-induced tumor necrosis factor synthesis in human mononuclear cells 

  14. Immunol. Today Eigler 18 487 1997 10.1016/S0167-5699(97)01118-3 Taming TNF: strategies to restrain this proinflammatory cytokine 

  15. Immunology Endres 72 56 1991 Cyclic nucleotides differentially regulate the synthesis of tumour necrosis factor-alpha and interleukin-1 beta by human mononuclear cells 

  16. J. Exp. Med. Florquin 180 1153 1994 10.1084/jem.180.3.1153 The protective role of endogenously synthesized nitric oxide in staphylococcal enterotoxin B-induced shock in mice 

  17. Nucleic Acids Res. Fransen 13 4417 1985 10.1093/nar/13.12.4417 Molecular cloning of mouse tumor necrosis factor cDNA and its eukaryotic expression 

  18. Arch. Surg. Fukatsu 130 410 1995 10.1001/archsurg.1995.01430040072016 Detrimental effects of a nitric oxide synthase inhibitor (N-omeganitro-L-arginine-methyl-ester) in a murine sepsis model 

  19. J. Cardiovasc. Pharmacol. Fülle 17 113 1991 10.1097/00005344-199117003-00021 Effects of SIN-1 on cytokine synthesis in human mononuclear cells 

  20. Goldfeld 87 9769 1990 Human tumor necrosis factor alpha gene regulation by virus and lipopolysaccharide 

  21. Anal. Biochem. Green 126 131 1982 10.1016/0003-2697(82)90118-X Analysis of nitrate, nitrite and [15-N]nitrite in biological fluids 

  22. Int. J. Immunopharmacol. Greten 17 605 1995 10.1016/0192-0561(95)00058-A The specific type IV phosphodiesterase inhibitor rolipram differentially regulates the proin-flammatory mediators TNF-α and nitric oxide 

  23. Haas 87 9563 1990 Molecular mechanisms in down-regulation of tumor necrosis factor expression 

  24. J. Exp. Med. Han 171 465 1990 10.1084/jem.171.2.465 Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level [published erratum appears in J. Exp. Med., 1990, Mar 1;171(3):971-2] 

  25. J. Exp. Med. Han 172 391 1990 10.1084/jem.172.1.391 Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway 

  26. J. Biol. Chem. Hattori 269 9405 1994 10.1016/S0021-9258(17)36893-X Arginin-osuccinate synthetase messenger RNA and activity are induced by immunostimulants in vascular smooth muscle - role in the regeneration of arginine for nitric oxide synthesis 

  27. J. Biol. Chem. Koide 268 24959 1993 10.1016/S0021-9258(19)74557-8 Cyclic AMP-elevating agents induce an inducible type of nitric oxide synthase in cultured vascular smooth muscle cells - synergism with the induction elicited by inflammatory cytokines 

  28. J. Biol. Chem. Liebermann 267 2123 1992 10.1016/S0021-9258(18)45850-4 Poly(A) removal is the kinase-regulated step in tumor necrosis factor mRNA decay 

  29. Lowenstein 89 6711 1992 Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme 

  30. Cell Lowenstein 70 705 1992 10.1016/0092-8674(92)90301-R Nitric oxide, a novel biologic messenger 

  31. Cell MacMicking 81 641 1995 10.1016/0092-8674(95)90085-3 Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase 

  32. Nature McGeehan 370 558 1994 10.1038/370558a0 Regulation of tumour necrosis factor-α by a metalloproteinase inhibitor 

  33. Nature Mohler 370 218 1994 10.1038/370218a0 Protection against a lethal dose of endotoxin by an inhibitor of tumor necrosis factor processing 

  34. N. Engl. J. Med. Moncada 329 2002 1993 10.1056/NEJM199312303292706 The L-arginine-nitric oxide pathway 

  35. J. Exp. Med. Moreira 177 1675 1993 10.1084/jem.177.6.1675 Thalidomide exerts its inhibitory action on tumor necrosis factor-alpha by enhancing messenger RNA degradation 

  36. J. Immunol. Mossman 65 55 1983 Rapid colorimetric assay for cellular growth and survival; application to proliferation and cytotoxicity assays 

  37. FASEB J. Nathan 6 3051 1992 10.1096/fasebj.6.12.1381691 Nitric oxide as a secretory product of mammalian cells 

  38. J. Biol. Chem. Nussler 269 1257 1994 10.1016/S0021-9258(17)42251-4 Coinduction of nitric oxide synthase and argininosuccinate synthetase in a murine macrophage cell line. Implications for regulation of nitric oxide production 

  39. J. Immunol. Parmely 151 389 1993 10.4049/jimmunol.151.1.389 Adenosine and a related carbocyclic nucleoside analogue selectively inhibit tumor necrosis factor-alpha production and protect mice against endotoxin challenge 

  40. Eur. J. Immunol. Reiling 24 1941 1994 10.1002/eji.1830240836 Nitric oxide synthase: mRNA expression of different isoforms in human monocytes/macrophages 

  41. Sambrook 1989 Molecular cloning: a laboratory handbook 

  42. J. Clin. Invest. Sariban 81 1506 1988 10.1172/JCI113482 Transcriptional and posttranscriptional regulation of tumor necrosis factor gene expression in human monocytes 

  43. Nucleic Acids Res. Semon 15 9083 1987 10.1093/nar/15.21.9083 Nucleotide sequence of the murine TNF locus, including the TNF-α (tumor necrosis factor) and TNF-β (lymphotoxin) genes 

  44. Cell Shaw 46 659 1986 10.1016/0092-8674(86)90341-7 A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation 

  45. Eur. J. Immunol. Sinha 25 147 1995 10.1002/eji.1830250125 Enhanced tumor necrosis factor suppression and cyclic adenosine monophosphate accumulation by combination of phophodiesterase inhibitors and prostanoids 

  46. J. Immunol. Tannenbaum 142 1274 1989 10.4049/jimmunol.142.4.1274 Lipopoly-saccharide-induced gene expression in murine peritoneal macrophages is selectively suppressed by agents that elevate intracellular cAMP 

  47. Surgery Tiao 116 332 1994 Detrimental effect of nitric oxide synthase inhibition during endotoxemia may be caused by high levels of tumor necrosis factor and interleukin-6 

  48. Annu. Rev. Med. Tracey 45 491 1994 10.1146/annurev.med.45.1.491 Tumor necrosis factor: a pleiotropic cytokine and therapeutic target 

  49. J. Immunol. Van Dervort 152 4102 1994 10.4049/jimmunol.152.8.4102 Nitric oxide regulates endotoxin-induced TNF-alpha production by human neutrophils 

  50. Biochem. J. Wu 281 45 1992 10.1042/bj2810045 Macrophages can convert citrulline into arginine 

  51. Science Xie 256 225 1992 10.1126/science.1373522 Cloning and characterization of inducible nitric oxide synthase from mouse macrophages 

  52. J. Immunol. Ziegler-Heitbrock 151 6986 1993 10.4049/jimmunol.151.12.6986 Pyrrolidine dithiocarbamate inhibits NF-κ B mobilization and TNF production in human monocytes 

  53. Eur. Cytokine Netw. Zinetti 6 45 1995 Endogenous nitric oxide production by human monocytic cells regulates LPS-induced TNF production 

관련 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로